ARCHIVES

Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS

This article is from The Cancer Letter archive.

Vol. 17 No. 37 | September 27, 1991

Download PDF Visit The Full Archive

Related Articles

Comment period for biospecimen network proposal extended.

January 16, 2004

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

Maggie’s Bill Pays Off; NCI Celebrates 40th

August 12, 1977

ASPO Hears Proposals For Economic Attacks On Tobacco Industry

April 7, 1989

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013